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Abstract
Lymphotoxin beta-receptor (LTbR) is involved in the formation and maintenance of secondary lymphoid structures, as
well as in the regulation of inflammatory responses. Because LTbR lymphoid structure formation continues to develop in
infants, we compared two different chimera models: one using adult mice and the other using a transplantation model of
neonatal mice. To elucidate the function of LTbR on lymphoid and non-lymphoid cells, we generated bone marrow
chimeras on the wild type C57Bl/6 and the LTbR-deficient (LTbR/) background, and reconstituted the mice with bone
marrow cells reciprocally. These chimeric mice were analyzed in the experimental model of acute dextran sulfate
sodium-induced colitis. Interestingly, both models revealed not only equal reconstitution levels but also similar immuno-
logical responses: LTbR expression on stromal cells is essential for lymph node formation, whereas LTBR on hemato-
poietic cells is crucial for a decrease in inflammation. In addition, mice lacking LTbR on hematopoietic cells revealed (a) an
increase of immature granulocytic cells in the spleen and (b) a reduced proportion of myeloid cells in peripheral blood
and spleen expressing CD11bþLy6CþLy6G (myeloid-derived suppressor cells expression profile). In conclusion, LTbR
expression on hematopoietic cells seems to be involved in the down-regulation of acute inflammatory reactions paral-
leled by the appearance of immature myeloid cells.
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Introduction
Lymphotoxin beta-receptor (LTbR) signaling is
involved in lymphoid organogenesis and the mainten-
ance of secondary lymphoid structures,1–3 as well as the
regulation of acute inﬂammatory reactions.1 Recent
studies described the importance of LTbR during dex-
tran sulfate sodium (DSS)-induced colitis by inhibition
of LTbR activation.4–6 Blocking of LTbR signaling was
achieved either by treatment with LTbR–Ig, a func-
tional inhibitor of LTbR signaling, or by congenital
deletion of the LTbR or its functional ligand lympho-
toxin (LT) a1b2.
LTbR also seems to be involved in the recruitment of
diﬀerent hematopoietic cells in lymphoid and non-
lymphoid compartments, including the recruitment of
B cells into the intestine7, denditric cells (DC) into the
spleen in particular and in lymphoid tissues in general.8,9
LTbR signaling is also essential for the development
and function of high endothelial venules,10 the induction
of lymphoid tissue chemokines and adhesion mol-
ecules11 and the expression of mucosal addressin cell
adhesion molecule-1 in DSS-induced intestinal inﬂam-
mation.12 These ﬁndings reveal the importance of LTbR
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and ligand interaction in the control of the traﬃcking of
lymphoid cells.
In addition, LTbR signaling is also important in the
maturation step, as well as the in situ survival of lymph-
oid cells. For example, the interaction between LTbR
on bone marrow (bm) stromal cells and LT on NK cells
is an important step in early NK cell development.
Furthermore, survival signals via LTbR activation pro-
tect lymphocytes from apoptosis, for instance during
virus infection.13 Hence, LTbR signaling clearly plays
a role in the control of local inﬂammatory reactions via
lymphocyte attraction, maturation and survival.
Given that LTbR and its ligands are involved in
lymphoid structure formation, which continues to
develop in early life,14–16 we generated bm chimeras
with neonatal or adult mice to compare the eﬀect of
LTbR signaling during maturation. Neonatal trans-
plantation of human haematopoietic stem cells is com-
monly used in the generation of ‘humanized’ mice, and
displayed high transplantation eﬃciency when trans-
planted into the liver of newborn mice.17,18
To elucidate the importance of LTbR signaling in
the control of inﬂammatory processes, these mice chi-
meras were subjected to DSS-induced colitis, which
represents a model of inﬂammatory bowel disease
(IBD). IBD comprises diﬀerent chronic or recurring
immune response, and inﬂammation of the gastrointes-
tinal tract. The main forms of IBD are Crohn’s disease
and ulcerative colitis, which can trigger the develop-
ment of colorectal cancer and limit the quality of life
in general. The etiology of IBD is still unknown and,
therefore, the only available treatments focus on unspe-
ciﬁc immunosuppression. In colitis, the role of LT func-
tion has been shown to be as important as the TNF-a
signaling for disease development and maintenance.
Therefore, understanding the role of activation of the
LTbR during this inﬂammatory disorder might lead to
the development of more speciﬁc treatment schedules
with reduced side eﬀects.
Materials and methods
Animal husbandry
Mice used in all experiments were housed under speciﬁc
pathogen-free conditions in the animal facility of the
University of Regensburg, Regensburg, Germany, and
regularly monitored for the absence of speciﬁc patho-
gens, as recommended by the Federation of Laboratory
Animal Science Associations.
Bm chimeras
Bm cells were isolated from femur, tibia and humerus
of donor mice [C57Bl/6, LTbR/ and C57Bl/6 mice
congenic for CD45.1 (Ly5.1)] ﬂushed out with cold
PBS, ﬁltered through a 40-mm nylon cell strainer and
centrifuged at 300 g at 4C for 10min. Neonatal trans-
plantations were performed by intrahepatic injection of
3 107 bm cells into 24–48-h-old mice 3 h after 5-gray
(Gy) radiation. Eight wks post-transplantation recon-
stitution levels of the donor cells were analyzed in the
peripheral blood by ﬂow cytometry.
Adult transplantation was performed by injection of
6 106 bm cells intravenously in mice at 8–10 wks of
age following two doses of 5-Gy radiation. Three and
6 wks post-transplantation peripheral blood was
obtained and analyzed for reconstitution levels of
donor cells as described for neonatal transplanted
mice. A total of 35 neonatal and 29 adult transplanted
chimeras were generated, and 30 (neonatal) and
29 (adult) mice used for colitis experiments.
DSS-induced colitis
Acute colitis was induced in all chimeras by addition of
3% DSS MP Biochemical (Solon, Ohio, USA) to the
drinking water for a period of 7 d.
The animals’ mass and general conditions were
monitored on a daily basis. On d 7, animals were sacri-
ﬁced and all organs were harvested for myeloperoxi-
dase (MPO), histology and single cell analyses in ﬂow
cytometry.
Disease score
Mice undergoing DSS treatment were monitored daily
and ﬁnally histology was performed 7 d after the begin-
ning of treatment to determine the disease score. The
classiﬁcation of each individual mouse was conducted
as described in Table 1.
MPO
To measure neutrophilic granulocyte inﬁltration tissue,
samples from the middle part of the colon were har-
vested and prepared as described previously.12
Brieﬂy, tissue samples were placed in a solution of
potassium phosphate buﬀer (50mmol/l, pH 6.0) con-
taining 0.5% (w/v) hexadecyltrimethylammonium
bromide (1ml/30mg tissue). After homogenization
Table 1. Disease score.
Score Description
0 No diseaseþ no diarrhea
1 Low-grade diarrhea
2 High-grade diarrhea
þ1 Bloody diarrhea
þ1 Bad general condition
þ1 Death during experiment
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(Ultra Turrax; IKA Labortechnik, Staufen, Germany),
samples were frozen and thawed three times, centrifuged
at 44,000 g at 4C for 20min, and 10 ml of the super-
natants were transferred into phosphate buﬀer
(pH 6.0) containing 0.17mg/ml 3,30-dimethoxy-
benzidine and 0.0005% hydrogen peroxide (H2O2).
The H2O2-dependent oxidation of 3,3
0-dimethoxybenzi-
dine was measured for MPO activity.
Single cell isolation from different organs
Single cells were isolated from peripheral blood and
from diﬀerent mouse tissues, such as spleen, lymph
nodes and bm, as described previously.19 Brieﬂy,
spleen and lymph nodes were cut into small pieces
and pressed through a 40-mm nylon ﬁlter using the
plunger of a 2ml syringe. Cells were washed with PBS
supplemented with 5% FCS and centrifuged at 300 g at
4C for 10min. For bm cells, femurs were collected,
both ends were clipped oﬀ and cells ﬂushed out with
PBS using a 25-G needle, ﬁltered through a 40-mm
nylon cell strainer and centrifuged at 300 g at 4C for
10min.
Flow cytometry
Reconstitution levels of donor cells in peripheral blood
were determined using CD45.1 phycoerythrin (PE)
(clone A20; Becton-Dickinson (BD) Biosciences (San
Jose, CA, USA)) and CD45.2 FITC-conjugated Abs
(clone 104; eBioscience) together with anti-CD3 APC
or Percp-Cy5.5 (clone 145-2C11; eBioscience) and anti-
B220 Percp-Cy5.5 (clone RA3-6B2; eBioscience (San
Diego, CA, USA)). Samples were further analyzed
using the following mAb from BD Bioscience (San
Diego, CA, USA): anti-Ly6C FITC or biotin (clone
Al-21), anti-Ly6G PE (clone 1A8), and anti-CD11b
FITC (clone M1/70). The following Abs from
eBioscience were used in addition: anti-Gr-1 APC
(clone RB6-8C5); anti-CD11c Alexa700 (clone N418);
anti-F480 Paciﬁc Blue (clone BM8). For detection of
LTbR-expressing cells, anti-LTbR biotin (clone 3C8)
from eBioscience was used. All samples were analyzed
using a FACSLSR II ﬂow cytometer with the Diva
software package Becton-Dickinson (BD) Biosciences
(San Jose, CA, USA). To reduce non-speciﬁc binding
of mAb, cells were incubated with anti-mouse Fc recep-
tor Abs (10 mg/ml; Sigma-Aldrich (Sigma-Aldrich,
Taufkirchen, Germany)) on ice for 20min before stain-
ing with speciﬁc mAb or isotype control mAb.
Histology
Animals were sacriﬁced by cervical dislocation. Colons
were isolated, measured for length and ﬂushed with
sterile PBS. Distal colon sections were ﬁxed in 4% neu-
tral buﬀered formalin, and 4-mm paraﬃn sections were
prepared. Specimens were de-paraﬃnized and pre-
treated by microwave heating for 30min at 320W in
0.1M citrate buﬀer adjusted to pH 7.3, followed by
hematoxylin and eosin (H&E) staining and histological
evaluation for colonic damage, as described in Table 2.
Statistics
Statistical analysis was performed using GraphPad’s
Prism software (GraphPad, La Jolla, CA, USA).
A Student’s t-test was applied for MPO, colon length
and ﬂow cytometric data. Two-way ANOVAþ
Bonferroni post-test were used for weight loss analyses,
and a Mann–Whitney rank sum test was employed for
histological score, disease score and colon length.
Signiﬁcance was set at P> 0.05.
Results
Bm transplantation of adult, as well as of neonatal,
mice led to high reconstitution levels in all organs, but
did not influence lymphoid structure formation
To elucidate the eﬀect of LTbR signaling during hem-
atopoiesis in a growing organism, we compared two
diﬀerent bm cell transplantation models in this study:
one transplantation method using adult mice (aged
8–10 wks) and a transplantation model using neonatal
mice (aged 24–48 h). Thus, we were able to compare the
inﬂuence of transplantation on immune cell diﬀerenti-
ation at an early stage of hematopoiesis with the adult
model. Importantly, both transplantation methods
revealed equally high reconstitution levels in all tissues,
including the peripheral blood, the bm, the spleen and
lymph nodes, independent of the time point of trans-
plantation (neonatal: Figure 1a; adult: Supplementary
Figure 1a). In both setups, reconstitution was stable for
more than 1 yr, but neonatal transplantation resulted in
decelerated growth of the animals owing to the irradi-
ation dose of 5Gy. Nevertheless, lymphoid structure
formation could not be rescued by the wild type (wt)
bm transplantation in LTBR/ neonatal mice as only
one out of 13 transplanted neonatal LTBR/ mice
Table 2. Histological score.
Score
Epithelial
damage Inflammatory infiltration
0 None None
1 None Infrequent
2 None Between crypts and lamina musc.
mucosae (mild)
3 Partial loss
of crypts
Moderate (þ edema)
4 Extensive loss
of crypts
Between lamina musc. mucosae and
submucosa (massive, extensive)
Musc.: lamina muscularis mucosae.
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Figure 1. LTbR/ bm-transplanted chimeras revealed aggravated signs of inflammation and tissue damage after DSS colitis. (a) Flow
cytometry of peripheral blood (pb) of bm reconstituted mice (neonatal transplantation; 14 wks post-transplant) analyzed by the
expression of the congenic markers Ly5.1 (CD45.1) in C57Bl/6 and LTbR/ mice, and Ly5.2 (CD45.2) in CD45.1 mice. Inflammation
and tissue damage after DSS-induced colitis were measured as MPO activity (b) in U/mg of protein isolated from the distal part of the
colon; histological score (d) representing mucosal damage and inflammatory infiltrates, as described in Table 2; and reduction of colon
length (e) as a marker of injury measured in cm of colon. (f) Mass was monitored daily during DSS treatment, and disease score (g) was
assessed on the day of sacrificing the animals (Table 1). (c) Representative H&E-stained colon section of C57Bl/6 mice transplanted
with CD45.1 bm, LTbR/ mice transplanted with CD45.1 bm and CD45.1 mice transplanted with LTbR/ bm. Bars represent
100 mm. Data were analyzed using Student’s t-test (MPO, colon length), one-way ANOVA (A*¼ P< 0.05)þTukey’s multiple com-
parison test (histological score, MPO) and two-way-ANOVAþBonferroni post-test (mass loss). Error bars represent means SEM.
*P< 0.05), **P< 0.01). ln: lymph nodes.
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developed mesenteric lymph nodes. These ﬁndings have
also been observed in adult transplantation in LTBR/
mice, which did not result in lymph node formation
(0/9). All other transplanted groups (including neonatal
wt mice transplanted with LTBR/ bm) developed
mesenteric lymph nodes (even; data not shown).
Chimeras transplanted with LTR-deficient bm
cells developed exacerbated inflammatory
reactions in DSS-induced colitis
After 7 d of DSS treatment, mice transplanted with
LTbR/ bm cells demonstrated (a) MPO activity,
indicating granulocyte inﬂux into the tissue
(Figure 1b, Supplementary Figure 1B) and (b) the
most serious tissue damage, including loss of crypts,
severe inﬂammatory inﬁltrates and loss of mucosal
architecture (Figure 1c), resulting in an increased histo-
logical score (Figure 1d) in both transplantation
models. In addition, the reduction of colon length as
a result of on-going inﬂammation was much more pro-
nounced in mice lacking LTbR on hematopoietic cells
than in mice lacking LTbR expression on stromal cells
(Figure 1e, Supplementary Figure 1C). Both trans-
plantation strategies revealed a signiﬁcant worsening
of disease and mass loss when bm cells lacked LTbR
expression (Figure 1f, g, Supplementary Figure 1D, E).
Thus, in both models LTBR deﬁciency led to an exacer-
bation of the inﬂammatory response upon DSS and
therefore supports the earlier ﬁnding that LTbR signal-
ing on hematopoietic cells (and not on stromal cells)
down-regulates exaggerated inﬂammation in a model
of acute DSS-induced colitis.6 This result was inde-
pendent of whether the bm transplantation occurred
in neonatal or adult animals.
Myeloid cell proportion increased in peripheral blood
after DSS-induced colitis
Peripheral blood of neonatally-transplanted chimeras
was analyzed by ﬂow cytometry 6, 10 and 14 wks after
bm transfer. The results show an increase of B cells
(Figure 2a) in parallel with a slight decrease of T cells
(Figure 2b) and myeloid cells (CD33þ; Figure 2c), inde-
pendently of whether mice were transplanted with
LTbR/ or LTbRþ/þ bm cells. Such changes in the
lymphocyte composition were not observed in adult
transplanted animals (data not shown), which already
had a solid B cell population 2 wks post-transplantation.
In both adult and neonatal chimera models an equal
change in cell composition was found after 7 d of DSS-
treatment characterized by a signiﬁcant decrease of the
B cell fraction (Figure 2a) paralleled by a signiﬁcant
increase of the myeloid cell fraction (Figure 2c).
Further characterization of the myeloid cells revealed
that these cells were positive for CD11c. The propor-
tion of these CD11cþ cells (Figure 2d) was similar in
both types of chimeras and independent of LTbR
expression. Two diﬀerent myeloid cell populations
were found. The larger fraction was characterized by
the markers CD11cþ Gr1þ Ly6Cþ (Figure 2e) and
located in the forward scatter (FSC)/side scatter (SSC)
area of granulocytic cells (Figure 2f, top arrow). The
smaller fraction with the proﬁle of CD11cþ Gr1
Ly6Cþ cells (Figure 2f, bottom arrow, Figure 2g) was
slightly higher in animals transplanted with LTbR/ bm.
Maturation of different splenic myeloid cell
population in mice transplanted neonatally
with LTR/ bm
Spleen cells serve as a reservoir for inﬂammatory mono-
cytes during inﬂammation, and extra-medullary prolifer-
ation of myeloid cells contributes massively to the
monocytic cell pool under inﬂammatory conditions.
Therefore, we further characterized diﬀerent subsets of
myloid cells in this lymphoid organ by ﬂow cytometry
(Figure 3), including macrophages (F480), DCs (CD11c)
and their subpopulations. Animals transplanted with
LTbR/ bm cells showed a signiﬁcantly lower percent-
age of macrophages (Figure 3d, left), but a higher pro-
portion of CD11cþ cells (Figure 3d, second graph). In all
chimeras the predominant population of F480þ macro-
phages was F480þ CD11c Gr1þ Ly6C (data not
shown). In contrast, the majority of CD11cþ cells were
Ly6cþþ GR1þþ (Figure 3d, third graph), and were
located in the FSC/SSC area of granulocytes.
Chimeras that had received LTbR/ bm cells
showed a reduced proportion of immature (F480þ
Gr1þ CD11c Ly6C) monocytic cells in the spleen,
independent of whether they had been transplanted as
neonates or adults (data not shown).
Signiﬁcant diﬀerences in myeloid subpopulation gen-
eration after DSS colitis were observed within a subset
of Ly6cþþ Gr1 cells. This population was signiﬁcantly
more reduced in adult and neonatal mice transplanted
with LTbR-deﬁcient hematopoietic cells (Figure 3d,
right graph). These cells could neither be assigned
to the population of mature DC (CD11cþ) nor
to macrophages (F480þ). Therefore, we also stained
for CD11b, which enables the separation of CD11bþ
Ly6cþ Ly6Gþ immature granulocytic and CD11bþ
Ly6cþ Ly6G immature monocytic populations
(Figure 3e, ﬁrst and second graph). Both of these sub-
sets of immature myeloid cells were reduced in
the blood and spleens of mice transplanted with
LTbR/ bm cells (Figure 3e).
Taken together, the lack of LTbR expression on
hematopoietic cells induced a slight shift from mature
macrophages toward DC and granulocytes. In add-
ition, a reduced proportion of immature myeloid cells
in mice transplanted with LTbR-deﬁcient bm was
observed in the spleen and in the peripheral blood
(Figure 3e).
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Of note, no signiﬁcant diﬀerences in T and B cell
proportion were detected in the spleen or the peripheral
blood of any chimeras after DSS-induced colitis (data
not shown).
Characterization of myeloid subpopulation
expressing LTR in peripheral blood, spleen and
lymph node after DSS-induced colitis
Chimeras that had been transplanted with bm cells
from wt mice were analyzed for their LTbR expression
proﬁle on hematopoietic cells. In peripheral blood, two
diﬀerent cell populations were positive for LTbR stain-
ing (Figure 4a, b). One population was characterized by
F480þ CD11c (Figure 4a, fourth graph) consisting of
Ly6C-negative and Ly6C-positive cells (Figure 4a, ﬁfth
graph). The other population in peripheral blood
(Figure 4b) and the LTbRþ populations in the spleen
(Figure 4c) did not express CD11c, F480 or GR-1, but
some cells displayed a high expression of Ly6C. Of
note, this CD11c- and F480-negative myeloid cell
subpopulation, which had the marker proﬁle typical
for immature monocytic inﬂammatory, or so-called
‘suppressor’ cells, was signiﬁcantly reduced in mice
that had been transplanted with LTbR/ bm cells
(Figure 3d, fourth graph). Only a few LTbR-
expressing cells were detectable in the lymph nodes,
mainly without expression of any of the tested markers
(Figure 4d).
Discussion
LTbR and its activation by the ligands LIGHT, LTa3
and LTa1b2 are involved in many immunologic pro-
cesses, including immune cell induction, activation and
recruitment, as well as lymphoid structure formation.
The important role of LTbR signaling in the DSS col-
itis model was described previously and showed an
enhanced inﬂammatory reaction when LTbR signaling
is blocked.4–6
Because the LT system is involved in the develop-
ment and maintenance of lymphoid structures in
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Figure 2. Cell composition in peripheral blood changes after DSS-induced colitis in all chimeras. Peripheral blood (pb) analyses of B
cells (a), T cells (b) and myeloid cells (c) in neonatal-transplanted chimeras 6, 10 and 14 wks post-transplant (without colitis) and at d 7
after DSS-induced colitis (arrow). Chimeras [CD45.1 bm in LTbR/ mice (n¼ 4), LTbR/ bm in CD45.1 mice (n¼ 5)] were analyzed
for CD11cþ cells (d) and their subsets CD11cþGr1þLy6cþ (E) and CD11cþGr1Ly6cþ (g). (f) Density plot of peripheral blood
showing two cell populations (indicated by arrows) that were increased after DSS colitis. Error bars represent means SEM. Data
were analyzed using Student’s t-test. *P< 0.05).
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general,1–3 and at the mucosal site of gut-associated
lymphoid tissue, in particular,20 we used two trans-
plantation models (neonatal and adult transplantation)
to determine whether the expression of LTbR at diﬀer-
ent time points during hematopoiesis inﬂuences disease
progression later in life.
Interestingly, both transplantation strategies
resulted in very similar ﬁndings: wt bm transplantation
in LTBR/ mice was not able to rescue lymphoid
structure formation, even when transplanted in new-
born mice. Therefore, lymphoid structure formation is
dependent on LTBR expression on stromal cells and
not on hematopoietic cells. The lack of mesenteric
lymph node formation in the LTBR/ recipients
does not seem to hinder acute inﬂammation processes
in the gut. LTBR/ and control mice (wtþwt bm)
demonstrated comparable immune response, shown
cumulatively by a similar inﬂammation proﬁle,
MPO activity, histological score and colon length.
Furthermore, it has been previously reported that
extra-lymphoid tissues play an important role in the
induction of immune responses.21,22 In addition,
LTBR/ mice revealed similar allograft rejection as
wt mice, but this graft-versus-host disease (GvHD)
reaction was delayed in splenectomized LTbR/
mice.23 Therefore, immune activation, which usually
occurs in the peripheral lymph nodes, can be compen-
sated for by the spleen in LTBR/ animals.
Nevertheless, the inﬂuence of missing lymph nodes in
LTBR/ mice during DSS-induced colitis cannot be
excluded completely.
During DSS-induced colitis, the lack of LTbR on
hematopoietic, but not on stromal, cells led to an
increase in inﬂammation and tissue damage, which
was clearly demonstrated by the very high inﬂamma-
tory cell inﬂux and MPO activity. These results indicate
that activation of the LTbR on hematopoietic and not
on stromal cells is essential for restraining the inﬂam-
mation. Thus, LTbR expression on hematopoietic cells
seems to be important to dampen on-going
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Figure 3. Characterization of myeloid subpopulations in different chimera subsets after DSS-induced colitis. Density plots showing
gating strategies for F480þ and CD11cþ cells (a) gated on live cells, Ly6cþ and Gr1þ of CD11cþ cells (b), and Ly6cþþ and Gr1þ of
CD11cF480 cells (c). GraphPad Prism illustration of spleen cells separated from neonatal-transplanted chimeras after DSS-induced
colitis (d) showing differences of myeloid cell fractions in mice transplanted with LTbR/ bm in the population of F480þ cells (first
graph), CD11cþ cells (second graph), CD11cþF480Gr1þþLy6cþþ (third graph) and CD11cF480Gr1Ly6cþþ cells (fourth graph).
(e) Dot plots representing CD11bþ and CD11cþ populations of live cells (first plot), and Ly6g and Ly6c on CD11bþ cells (second plot)
in peripheral blood (PB). Graphs of pooled mice samples (n¼ 3) from peripheral blood and spleen of CD45.1 mice transplanted with
LTbR/ bm and CD45.1 mice transplanted with C57Bl/6 bm. Graphs represent the percentage of CD11bþ cells (left graph),
CD11bþLy6cþLy6gþ and CD11bþLy6cþþLy6g of live cells (right graph). Error bars represent means SEM. Data were analyzed
using one-way ANOVA (A*¼ P< 0.05) and Tukey’s multiple comparison test. *P< 0.05), **P< 0.01.
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inﬂammation, and to block the recruitment and prolif-
eration of inﬂammatory cells in the tissue.
Characterization of diﬀerent peripheral blood sub-
populations after DSS-colitis showed an LTbR-inde-
pendent signiﬁcant reduction of B cells and increase
of myeloid cells. The main subpopulation of the
increased myeloid cell fraction in all chimeras were
characterized as granulocytes (CD11cþGr1þLy6Cþ),
which also entered the intestinal area, as indicated by
the MPO activity.
Because LTbR/ mice do not generate lymph
nodes, we analyzed spleens as lymphoid organs to
look for diﬀerences in the hematopoietic cell fraction.
None of the chimeras showed signiﬁcant variations in
the splenic B and T cell fractions. However, diﬀerences
in the myeloid cell fraction were found. Chimeras (adult
and neonatal transplanted) that lacked LTbR on hem-
atopoietic cells showed signiﬁcantly fewer macro-
phages, and a signiﬁcantly reduced myeloid cell
population, which lacked F480, CD11c and Gr1 mar-
kers, but expressed Ly6C. Interestingly, this
population of immature myeloid inﬂammatory cells
was also partly positive for LTbR expression in
blood, spleen and lymph nodes in chimeras trans-
planted with wt bm.
We further characterized this fraction as CD11bþ
cells being either Ly6C- and Ly6G-positive or
Ly6Chigh Ly6G-negative. Both cell populations were
reduced in chimeras transplanted with LTbR/ bm.
These subsets of CD11bþ cells are also described as
immature granulocytic or monocytic cells, respectively.
They belong to the immature myeloid cell lineage with
immunosuppressive functions [myeloid-derived sup-
pressor cells (MDSC)] and were decreased in chimeras
without LTbR on hematopoietic cells.
Such suppressive immature cells represent a hetero-
geneous population24–27 with multiple immunosuppres-
sive functions27–33 and have been described in
tumors,25,34–36 infection,37–39 and during GvHD40 and
auto-immune encephalitis.41 Importantly, these cells
were also involved in the regulation of IBD by inhibit-
ing T cell-mediated intestinal injury.42
Figure 4. LTbR expression on different cell populations in peripheral blood, spleen and lymph node after DSS-induced colitis. (a–d
first plot) Morphology plot of peripheral blood, spleen and lymph node of chimeras transplanted with wt bm. The second and third
plots display isotype and LTbR staining of gated live cells from the population indicated in the morphology plot (arrows). Third (and
fourth) plot outlines CD11c and F480 (and Ly6c and Gr, respectively) expression profile of LTbRþ cells.
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The highest degree of intestinal inﬂammation in our
chimeras reconstituted with LTbR/ bm was seen in
mice where such immature myeloid cells were reduced.
Interestingly, this myeloid subpopulation expressed
LTbR in wt chimeras. Therefore, LTbR expression on
hematopoietic cells might be involved in induction or
recruitment of immature myeloid cells in colitis, result-
ing in amelioration of inﬂammation.
Conclusions
In conclusion, our experiments indicate that activation
of the LTbR could play a role in the induction or
recruitment of myeloid suppressor cells in inﬂammatory
processes. The results of the present study demonstrate
that LTBR expression on stromal cells is essential for
lymph node formation, whereas the regulation of
inﬂammation is controlled by LTBR expression on
hematopoietic cells. In addition, the maturation of mye-
loid subpopulation is also inﬂuenced by LTBR expres-
sion, and lack of this receptor results in an increased
proportion of DCs, and reduced proportion of macro-
phages and myeloid progenitor cells (MDSCs).
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